Comparative Analysis for Reduction in A1c in Dapagliflozin Versus Glimepiride Monotherapy in Non-Obese Type 2 Diabetic Patients. mfm [Internet]. 2021 Jul. 12 [cited 2026 Jul. 10];32(6). Available from: https://medicalforummonthly.com/index.php/mfm/article/view/1680